Diabetes Mellitus and Vitamin D Deficiency:Comparable Effect on Survival and a DeadlyAssociation after a Myocardial...

Area of Science:

• Cardiology
• Endocrinology
• Nutritional Science

Background:

• Patients surviving myocardial infarction (MI) face elevated risks for subsequent cardiovascular events, particularly those with diabetes mellitus (DM).
• Vitamin D deficiency (hypovitaminosis D or hypovitD) is increasingly recognized as a potential comorbidity affecting cardiovascular health.
• Understanding the combined impact of DM and hypovitD on post-MI prognosis is crucial for developing targeted interventions.

Purpose of the Study:

• To investigate the independent and combined effects of diabetes mellitus and hypovitaminosis D on the prognosis of patients who have survived a myocardial infarction.
• To identify potential synergistic interactions between DM and hypovitD in influencing adverse cardiovascular outcomes post-MI.

Main Methods:

• A prospective, observational study involving 1081 patients surviving an MI.
• Patients were stratified into four groups based on their diabetic and vitamin D status.
• The primary endpoint was a composite of all-cause mortality, recurrent angina/MI, and heart failure (HF), with secondary outcomes including individual components.

Main Results:

• Both DM and hypovitD were associated with similar adjusted risks for the primary composite endpoint compared to patients without these conditions.
• Patients with both DM and hypovitD exhibited a significantly higher adjusted risk (HR 1.69) for the primary composite endpoint compared to those with neither condition.
• Individual components of the composite endpoint (angina, HF, mortality) showed no significant difference between patients with isolated DM or hypovitD.

Conclusions:

• Diabetes mellitus and hypovitaminosis D are independently associated with worse outcomes after myocardial infarction.
• A synergistic adverse effect exists when both diabetes mellitus and hypovitaminosis D are present in post-MI patients.
• These findings suggest that managing vitamin D status in diabetic MI survivors may offer a novel therapeutic strategy to improve prognosis.